US7785823B2 - Method for selective separation of free-astaxanthin from green algae Haematococcus pluvialis - Google Patents

Method for selective separation of free-astaxanthin from green algae Haematococcus pluvialis Download PDF

Info

Publication number
US7785823B2
US7785823B2 US11/677,302 US67730207A US7785823B2 US 7785823 B2 US7785823 B2 US 7785823B2 US 67730207 A US67730207 A US 67730207A US 7785823 B2 US7785823 B2 US 7785823B2
Authority
US
United States
Prior art keywords
astaxanthin
free
solvent
extract
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US11/677,302
Other versions
US20070196894A1 (en
Inventor
Sang-jun SIM
Chang-deok KANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sungkyunkwan University
Original Assignee
Sungkyunkwan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sungkyunkwan University filed Critical Sungkyunkwan University
Assigned to SUNGKYUNKWAN UNIVERSITY reassignment SUNGKYUNKWAN UNIVERSITY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KANG, CHANG-DEOK, SIM, SANG-JUN
Publication of US20070196894A1 publication Critical patent/US20070196894A1/en
Application granted granted Critical
Publication of US7785823B2 publication Critical patent/US7785823B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes

Definitions

  • the present invention relates to a method of separating free-astaxanthin selectively from green algae and, more particularly, to a method of separating free-astaxanthin selectively from a green microalgae Haematococcus pluvialis.
  • Red ketocarotenoid astaxanthin is a kind of carotenoid pigment having the same chemical structure as ⁇ -carotene, and is an anti-oxidizing material having an ability of removing detrimental activated oxygen that causes aging or a cancer. Astaxanthin has outstandingly higher anti-oxidizing activity than that of an existing anti-oxidizing material since it has a unique molecular structure having one more a hydroxyl group (—OH) and a ketone group ( ⁇ O) at both end groups compared to ⁇ -carotene.
  • the anti-oxidizing activity of astaxanthin is about 500-fold higher than representative anti-oxidizing agent vitamin E, and about 20-fold higher than ⁇ -carotene. Due to such high anti-oxidizing activity, astaxanthin is being widely used as a pharmaceutical, a food additive, and a feed additive for an animal and a fry. Further, it is expected that the demand and the application range for astaxanthin be rapidly expanded.
  • a method of producing astaxanthin includes a chemical synthesis, a method of extracting from shells of the Crustacea such as a crab and a shrimp, and a direct synthesis employing microorganism strains Phaffia rhodozyma and Haematococcus pluvialis.
  • the astaxanthin synthesized by chemical synthesis has less in vivo absorption rate than that of natural one, has a problem in safety as a food additive, and thus FDA approval was not given to it as a food additive. Only some countries such as Norway, Chile and Canada approve it as a food additive.
  • natural astaxanthin is deposited on a living organism in high concentration compared to synthetic astaxanthin, natural astaxanthin have been produced from byproducts of a shrimp or a crab, however, there is a problem that the natural astaxanthin thus produced is not suitable as an astaxanthin source due to the difficulty in its separation and purification process.
  • H. pluvialis Green algae H. pluvialis has problems of low growth rate, thick cell wall and low cell density, even though it has outstandingly high amount of accumulated astaxanthin compared to yeast P. rhodozyma . Therefore, H. pluvialis is behind P. rhodozyma having high growth rate in preference and industrial applicability, but is deemed to be the most promising strain since 3S, 3S′ astaxanthin isomer that only Haematococcus species possess is assumed to elevate the stability at lipid environment.
  • a method of recovering the representative Haematococcus astaxanthin proposed hitherto includes a mechanical method of extracting astaxanthin by freezing a strain from which water is completely removed with liquid nitrogen, then pulverizing it with an impact mill, and then disrupting the cell wall of the strain; a physical method of extracting astaxanthin with a solvent after disrupting the cell wall of the strain with a machine such as a physical homogenizer; a biological method of extracting astaxanthin after disrupting the cell wall of the strain by employing an enzyme disrupting a cell wall, i.e., cellulase, pectinase, protease, etc.
  • the present invention is directed to provide a method of separating free-astaxanthin selectively by employing two step-two phase solvent extraction process capable of maximizing the separation of free-astaxanthin from a strain for industrial application of Haematococcus astaxanthin.
  • Another object of the present invention is to provide a method of extracting and separating a carotenoid analogue including astaxanthin from a useful microalgae culture containing Haematococcus species through the above method.
  • An exemplary embodiment of the present invention provides a method of separating free-astaxanthin selectively from green microalgae H. pluvialis by employing two step-two phase solvent extraction process consisting of alkanic solvent extraction and continuous alcoholic solvent extraction.
  • the present invention provides a method of separating free-astaxanthin selectively from Haematococcus pluvialis , and the method comprises mixing a cell culture containing Haematococcus pluvialis with an alkanic solvent and stirring, thereby obtaining an alkanic solvent extract containing astaxanthin material including free-astaxanthin and astaxanthin ester (step 1); and mixing the alkanic solvent extract with an alcohol and stirring, thereby obtaining an alcoholic extract containing free-astaxanthin (step 2).
  • FIG. 1 shows a schematic diagram depicting the two step-two phase solvent extraction process for selective separation of free-astaxanthin used in an embodiment of the present invention
  • FIG. 2 shows graphs depicting HPLC chromatograms of the dodecane extract of the step 1 and the methanol extract of the step 2 in the two step-two phase solvent extraction process, respectively;
  • FIG. 3 shows a graph depicting the comparative results of free-astaxanthin extraction when adding sodium hydroxide (Example 1) and when not adding sodium hydroxide (Comparative example 1) in the two step extraction process from Haematococcus pluvialis cyst cell into methanol solvent; and
  • FIG. 4 shows a graph depicting the results of the extraction rate for free-astaxanthin by reuse of the dodecane solvent as an extracting solvent in the step 1.
  • step 1 an alkanic solvent extract containing astaxanthin material is obtained from green microalgae H. pluvialis . More particularly, a cell culture is incorporated into the alkanic solvent extraction step, thereby extracting the astaxanthin material within a cell into the alkanic solvent through vigorous mixing with the alkanic solvent.
  • H. pluvialis used in the present invention is a form of a red cyst cell directed to a resting stage, and accumulates high concentration of astaxanthin therein.
  • Astaxanthin accumulated in H. pluvialis is generally a mixed form of a free form and an ester form in which fatty acids are connected to terminal groups of the free-astaxanthin by ester bond (linkage), wherein the major fatty acid constituting the ester is C 18:1 (oleic acid). Accordingly, hydrophobic astaxanthin drained out by cell wall loss is quickly extracted into an alkanic solvent that is a hydrophobic solvent.
  • the alkanic solvents that can be used in the present invention are all alkanic solvents capable of extracting astaxanthin material.
  • solvents selected from the group consisting of linear or branched C 1 ⁇ C 20 alkanes can be used, and dodecane can be particularly used.
  • the amount of the alkanic solvent can be controlled according to the concentration of the cell culture, and can be easily controlled without undue experiments to those skilled in the art.
  • the cell culture and the alkanic solvent can be used in 1:1 volume ratio.
  • the alkanic solvent can separate the alkanic solvent extract containing astaxanthin material simply through spontaneous separation by density difference since an alkanic solvent is easily phase-separated from a cell culture.
  • the step 2 obtains an alcohol extract containing free-astaxanthin by employing an alcohol. More particularly, the alkanic solvent extract separated in the step 1 is mixed with an alcohol solvent in the extraction process of the step 2, and after standing, the astaxanthin material is extracted into the alcoholic solvent.
  • the alcohols that can be used in the present invention are all alcohols capable of extracting free-astaxanthin material.
  • alcohols selected from the group consisting of linear or branched C 1 ⁇ C 6 alcohols can be used, and methanol can be particularly used.
  • the amount of the alcohol can be controlled according to the concentration of the alkanic solvent extract, and can be easily controlled without undue experiments to those skilled in the art.
  • the alkanic solvent extract and the alcohol can be used in 1:1 volume ratio.
  • the astaxanthin ester material is induced into the free-astaxanthin form by adding an aqueous solution of sodium hydroxide to the alcohol solvent, thereby hydrolyzing the ester bond at both ends of astaxanthin, and the converted free-astaxanthin is continually extracted into the alcohol solvent. Consequently, the free-astaxanthin is completely extracted into the alcohol solvent, and the free-astaxanthin extract is very easily separated since an alkanic solvent and an alcoholic solvent are spontaneously phase-separated due to their density difference.
  • spontaneous standing time, extracting time and temperature for phase separation process were not described, since they can be variously controlled depending on the amount and concentration of the cell culture, and those skilled in the art can select them without undue experiments. Therefore, those parameters are not limited to a specific range in the present invention.
  • the alkane solvents from which the astaxanthin material is completely extracted hardly comprise the astaxanthin material, and thus are recycled to the extracting process of the step 1 and can be repeatedly used in extracting astaxanthin material from H. pluvialis cell culture ( FIG. 1 ).
  • the method for selective separation according to the present invention can be used in extracting and separating a carotenoid analogue including astaxanthin from not only Haematococcus pluvialis but also useful microalgae culture.
  • the specific reaction solvent and reaction condition can vary depending on the specific microalgae, but the extraction process of the step 1 using an alkanic solvent and the extraction process of the step 2 using an alcohol can be performed identically and a desired carotenoid analogue can be easily separated.
  • a well-cultured red H. pluvialis cyst cell was subjected to two step-two phase solvent extraction process shown in FIG. 1 , thereby separating free-astaxanthin selectively with high efficiency.
  • Step 1 A cell culture containing H. pluvialis cyst cell and an alkane solvent dodecane were incorporated into the extraction process of the step 1 with 1:1 volume ratio, and then were mixed vigorously. After cell wall loss and extraction of astaxanthin into the dodecane solvent are completed, the mixed solution was standing for a few minutes, and the dodecane extract was spontaneously phase-separated from the cell culture by density difference.
  • Step 2 The dodecane extract obtained from the step 1 was incorporated into the extraction process of the step 2, and then was mixed with an alcohol solvent methanol with 1:1 volume ratio. Most of the astaxanthin extract in dodecane had astaxanthin ester form as ascertained in the result of HPLC analysis shown in FIG. 2 . Methanol used in the extraction process of step 2 in order to convert various astaxanthin ester material contained in those dodecanes to free-astaxanthin form was a methanol in which 0.02M sodium hydroxide are dissolved. After two phase solvent extraction with dodecane and methanol for a few hours, free-astaxanthin was obtained from the methanol with a recovery rate more than 95% ( FIGS. 2 and 3 ), and the separation of the methanol extract was also performed by spontaneous standing due to density difference as the same as in the dodecane extract.
  • Example 2 This example was performed as the same in Example 1 except that pure methanol was used instead of the methanol in which 0.02M sodium hydroxides (NaOH) are dissolved in the extraction process of the step 2.
  • 0.02M sodium hydroxides NaOH
  • Example 1 Since the dodecane from which the astaxanthin material was completely extracted in Example 1 hardly comprised astaxanthin material, the dodecane was recycled to the extraction process of the step 1 and reused in extracting astaxanthin material from H. pluvialis cell culture. The process of extracting free-astaxanthin from the dodecane extract was performed as the same as in Example 1, and the results are shown in FIG. 4 .
  • the present invention can not only maximize the efficiency of separating astaxanthin in high concentration by providing a very simple process technique capable of recovering free-astaxanthin selectively from H. pluvialis culture with high efficiency, but also realize the economical and simple operation of the process of separating free-astaxanthin by repeatedly using an alkanic solvent as a mediating solvent for extracting free-astaxanthin.

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

There is provided a method of separating free-astaxanthin selectively from green algae and, more particularly, to a method of separating free-astaxanthin selectively from Haematococcus pluvialis, the method comprising: mixing a cell culture containing Haematococcus pluvialis with an alkanic solvent and stirring, thereby obtaining an alkanic solvent extract containing astaxanthin material including free-astaxanthin and astaxanthin ester (step 1); and mixing the alkanic solvent extract with an alcohol and stirring, thereby obtaining an alcoholic extract containing free-astaxanthin (step 2).

Description

CROSS-REFERENCE TO RELATED APPLICATION
This application claims the benefit of Korean Patent Application No. 10-2006-0016826, filed Feb. 21, 2006, the disclosure of which is hereby incorporated herein by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Technical Field
The present invention relates to a method of separating free-astaxanthin selectively from green algae and, more particularly, to a method of separating free-astaxanthin selectively from a green microalgae Haematococcus pluvialis.
2. Discussion of Related Art
Red ketocarotenoid astaxanthin is a kind of carotenoid pigment having the same chemical structure as β-carotene, and is an anti-oxidizing material having an ability of removing detrimental activated oxygen that causes aging or a cancer. Astaxanthin has outstandingly higher anti-oxidizing activity than that of an existing anti-oxidizing material since it has a unique molecular structure having one more a hydroxyl group (—OH) and a ketone group (═O) at both end groups compared to β-carotene. The anti-oxidizing activity of astaxanthin is about 500-fold higher than representative anti-oxidizing agent vitamin E, and about 20-fold higher than β-carotene. Due to such high anti-oxidizing activity, astaxanthin is being widely used as a pharmaceutical, a food additive, and a feed additive for an animal and a fry. Further, it is expected that the demand and the application range for astaxanthin be rapidly expanded.
A method of producing astaxanthin includes a chemical synthesis, a method of extracting from shells of the Crustacea such as a crab and a shrimp, and a direct synthesis employing microorganism strains Phaffia rhodozyma and Haematococcus pluvialis.
The astaxanthin synthesized by chemical synthesis has less in vivo absorption rate than that of natural one, has a problem in safety as a food additive, and thus FDA approval was not given to it as a food additive. Only some countries such as Norway, Chile and Canada approve it as a food additive.
Following research results that natural astaxanthin is deposited on a living organism in high concentration compared to synthetic astaxanthin, natural astaxanthin have been produced from byproducts of a shrimp or a crab, however, there is a problem that the natural astaxanthin thus produced is not suitable as an astaxanthin source due to the difficulty in its separation and purification process.
Consequently, biosynthesis through strain cell culture is required for producing natural astaxanthin. Strains that can be used industrially include P. rhodozyma and H. pluvialis. Green algae H. pluvialis has problems of low growth rate, thick cell wall and low cell density, even though it has outstandingly high amount of accumulated astaxanthin compared to yeast P. rhodozyma. Therefore, H. pluvialis is behind P. rhodozyma having high growth rate in preference and industrial applicability, but is deemed to be the most promising strain since 3S, 3S′ astaxanthin isomer that only Haematococcus species possess is assumed to elevate the stability at lipid environment. Accordingly, for industrial application for astaxanthin by Haematococcus species, not only relevant techniques for cell culture in high concentration and for producing astaxanthin in high concentration, but also techniques for recovering the astaxanthin accumulated in a cell with high efficiency must be developed. Particularly, the techniques for culturing photosynthetic microalgae in high concentration have been actively developed through development of photo incubator, etc., but the techniques for separating Haematococcus astaxanthin in high concentration have not been actively developed. Therefore, a method of obtaining astaxanthin extract with high purity has not been developed for industrial scale.
A method of recovering the representative Haematococcus astaxanthin proposed hitherto includes a mechanical method of extracting astaxanthin by freezing a strain from which water is completely removed with liquid nitrogen, then pulverizing it with an impact mill, and then disrupting the cell wall of the strain; a physical method of extracting astaxanthin with a solvent after disrupting the cell wall of the strain with a machine such as a physical homogenizer; a biological method of extracting astaxanthin after disrupting the cell wall of the strain by employing an enzyme disrupting a cell wall, i.e., cellulase, pectinase, protease, etc. However, these methods have problems of low extraction speed, high disruption rate for astaxanthin, much labor force and high process cost, etc., and thus are not put to practical use. Accordingly, for industrial mass production of astaxanthin employing Haematococcus species, there is needed for a new process of separating astaxanthin capable of recovering astaxanthin in high concentration from a strain with high efficiency.
SUMMARY OF THE INVENTION
Therefore, the present invention is directed to provide a method of separating free-astaxanthin selectively by employing two step-two phase solvent extraction process capable of maximizing the separation of free-astaxanthin from a strain for industrial application of Haematococcus astaxanthin.
Another object of the present invention is to provide a method of extracting and separating a carotenoid analogue including astaxanthin from a useful microalgae culture containing Haematococcus species through the above method.
An exemplary embodiment of the present invention provides a method of separating free-astaxanthin selectively from green microalgae H. pluvialis by employing two step-two phase solvent extraction process consisting of alkanic solvent extraction and continuous alcoholic solvent extraction.
In accordance with an exemplary embodiment, the present invention provides a method of separating free-astaxanthin selectively from Haematococcus pluvialis, and the method comprises mixing a cell culture containing Haematococcus pluvialis with an alkanic solvent and stirring, thereby obtaining an alkanic solvent extract containing astaxanthin material including free-astaxanthin and astaxanthin ester (step 1); and mixing the alkanic solvent extract with an alcohol and stirring, thereby obtaining an alcoholic extract containing free-astaxanthin (step 2).
BRIEF DESCRIPTION OF THE DRAWINGS
The above and other features and advantages of the present invention will become more apparent to those of ordinary skill in the art by describing in detail preferred embodiments thereof with reference to the attached drawings in which:
FIG. 1 shows a schematic diagram depicting the two step-two phase solvent extraction process for selective separation of free-astaxanthin used in an embodiment of the present invention;
FIG. 2 shows graphs depicting HPLC chromatograms of the dodecane extract of the step 1 and the methanol extract of the step 2 in the two step-two phase solvent extraction process, respectively;
FIG. 3 shows a graph depicting the comparative results of free-astaxanthin extraction when adding sodium hydroxide (Example 1) and when not adding sodium hydroxide (Comparative example 1) in the two step extraction process from Haematococcus pluvialis cyst cell into methanol solvent; and
FIG. 4 shows a graph depicting the results of the extraction rate for free-astaxanthin by reuse of the dodecane solvent as an extracting solvent in the step 1.
 DETAILED DESCRIPTION OF THE INVENTION
The present invention will now be described more fully hereinafter with reference to the accompanying drawings, in which preferred embodiments of the invention are shown. This invention may, however, be embodied in different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided as teaching examples of the invention.
In step 1, an alkanic solvent extract containing astaxanthin material is obtained from green microalgae H. pluvialis. More particularly, a cell culture is incorporated into the alkanic solvent extraction step, thereby extracting the astaxanthin material within a cell into the alkanic solvent through vigorous mixing with the alkanic solvent.
H. pluvialis used in the present invention is a form of a red cyst cell directed to a resting stage, and accumulates high concentration of astaxanthin therein. Astaxanthin accumulated in H. pluvialis is generally a mixed form of a free form and an ester form in which fatty acids are connected to terminal groups of the free-astaxanthin by ester bond (linkage), wherein the major fatty acid constituting the ester is C18:1 (oleic acid). Accordingly, hydrophobic astaxanthin drained out by cell wall loss is quickly extracted into an alkanic solvent that is a hydrophobic solvent.
The alkanic solvents that can be used in the present invention are all alkanic solvents capable of extracting astaxanthin material. For example, solvents selected from the group consisting of linear or branched C1˜C20 alkanes can be used, and dodecane can be particularly used. The amount of the alkanic solvent can be controlled according to the concentration of the cell culture, and can be easily controlled without undue experiments to those skilled in the art. Particularly, the cell culture and the alkanic solvent can be used in 1:1 volume ratio.
Further, the alkanic solvent can separate the alkanic solvent extract containing astaxanthin material simply through spontaneous separation by density difference since an alkanic solvent is easily phase-separated from a cell culture.
The step 2 obtains an alcohol extract containing free-astaxanthin by employing an alcohol. More particularly, the alkanic solvent extract separated in the step 1 is mixed with an alcohol solvent in the extraction process of the step 2, and after standing, the astaxanthin material is extracted into the alcoholic solvent.
The alcohols that can be used in the present invention are all alcohols capable of extracting free-astaxanthin material. For example, alcohols selected from the group consisting of linear or branched C1˜C6 alcohols can be used, and methanol can be particularly used. The amount of the alcohol can be controlled according to the concentration of the alkanic solvent extract, and can be easily controlled without undue experiments to those skilled in the art. Particularly, the alkanic solvent extract and the alcohol can be used in 1:1 volume ratio.
Meanwhile, a process of converting a highly hydrophobic ester material into a free-astaxanthin form through breaking the ester bond is needed since the highly hydrophobic ester material has a high tendency of remaining in the alkanic solvent. Accordingly, in the present invention, the astaxanthin ester material is induced into the free-astaxanthin form by adding an aqueous solution of sodium hydroxide to the alcohol solvent, thereby hydrolyzing the ester bond at both ends of astaxanthin, and the converted free-astaxanthin is continually extracted into the alcohol solvent. Consequently, the free-astaxanthin is completely extracted into the alcohol solvent, and the free-astaxanthin extract is very easily separated since an alkanic solvent and an alcoholic solvent are spontaneously phase-separated due to their density difference.
Methods of obtaining free-astaxanthin from the alcohol extract thereafter are known to the art, and, for example, free-astaxanthin can be easily obtained by solvent evaporation.
In describing the present invention, spontaneous standing time, extracting time and temperature for phase separation process were not described, since they can be variously controlled depending on the amount and concentration of the cell culture, and those skilled in the art can select them without undue experiments. Therefore, those parameters are not limited to a specific range in the present invention.
Meanwhile, the alkane solvents from which the astaxanthin material is completely extracted hardly comprise the astaxanthin material, and thus are recycled to the extracting process of the step 1 and can be repeatedly used in extracting astaxanthin material from H. pluvialis cell culture (FIG. 1).
The method for selective separation according to the present invention can be used in extracting and separating a carotenoid analogue including astaxanthin from not only Haematococcus pluvialis but also useful microalgae culture. The specific reaction solvent and reaction condition can vary depending on the specific microalgae, but the extraction process of the step 1 using an alkanic solvent and the extraction process of the step 2 using an alcohol can be performed identically and a desired carotenoid analogue can be easily separated.
The present invention will be described in greater detail with reference to the following examples and the comparative example. However, the following examples are for illustrative purposes only and are not intended to limit the scope of the invention.
Example 1 Selective Separation of Free-Astaxanthin
A well-cultured red H. pluvialis cyst cell was subjected to two step-two phase solvent extraction process shown in FIG. 1, thereby separating free-astaxanthin selectively with high efficiency.
(Step 1) A cell culture containing H. pluvialis cyst cell and an alkane solvent dodecane were incorporated into the extraction process of the step 1 with 1:1 volume ratio, and then were mixed vigorously. After cell wall loss and extraction of astaxanthin into the dodecane solvent are completed, the mixed solution was standing for a few minutes, and the dodecane extract was spontaneously phase-separated from the cell culture by density difference.
(Step 2) The dodecane extract obtained from the step 1 was incorporated into the extraction process of the step 2, and then was mixed with an alcohol solvent methanol with 1:1 volume ratio. Most of the astaxanthin extract in dodecane had astaxanthin ester form as ascertained in the result of HPLC analysis shown in FIG. 2. Methanol used in the extraction process of step 2 in order to convert various astaxanthin ester material contained in those dodecanes to free-astaxanthin form was a methanol in which 0.02M sodium hydroxide are dissolved. After two phase solvent extraction with dodecane and methanol for a few hours, free-astaxanthin was obtained from the methanol with a recovery rate more than 95% (FIGS. 2 and 3), and the separation of the methanol extract was also performed by spontaneous standing due to density difference as the same as in the dodecane extract.
Comparative Example 1
This example was performed as the same in Example 1 except that pure methanol was used instead of the methanol in which 0.02M sodium hydroxides (NaOH) are dissolved in the extraction process of the step 2.
The results are shown in FIG. 3 comparing with the results in Example 1. In this comparative example, since hydrolysis reaction by sodium hydroxide did not occur, the conversion of the astaxanthin ester material to free-astaxanthin did not occur. Accordingly, the proportion of free-astaxanthin extracted into methanol was outstandingly low compared to Example 1 as can be seen in FIG. 3.
Example 2 Separation Method Employing the Recycled Dodecane
Since the dodecane from which the astaxanthin material was completely extracted in Example 1 hardly comprised astaxanthin material, the dodecane was recycled to the extraction process of the step 1 and reused in extracting astaxanthin material from H. pluvialis cell culture. The process of extracting free-astaxanthin from the dodecane extract was performed as the same as in Example 1, and the results are shown in FIG. 4.
As shown in FIG. 4, even though the dodecane solvent was recycled and reused 3 times, the recovery rate of astaxanthin was more than 80% compared to that in case of using new dodecane solvent.
As described in the above, the present invention can not only maximize the efficiency of separating astaxanthin in high concentration by providing a very simple process technique capable of recovering free-astaxanthin selectively from H. pluvialis culture with high efficiency, but also realize the economical and simple operation of the process of separating free-astaxanthin by repeatedly using an alkanic solvent as a mediating solvent for extracting free-astaxanthin.
The invention has been described using preferred exemplary embodiments. However, it is to be understood that the scope of the invention is not limited to the disclosed embodiments. On the contrary, the scope of the invention is intended to include various modifications and alternative arrangements within the capabilities of persons skilled in the art using presently known or future technologies and equivalents. The scope of the claims, therefore, should be accorded the broadest interpretation so as to encompass all such modifications and similar arrangements.

Claims (2)

1. A method of separating free-astaxanthin selectively from Haematococcus pluvialis, the method comprising:
mixing a cell culture containing Haematococcus pluvialis with a dodecane solvent with 1:1 volume ratio and stirring, thereby obtaining a dodecane solvent extract containing astaxanthin material including free-astaxanthin and astaxanthin ester (step 1);
mixing the dodecane solvent extract with a methanol with 1:1 volume ratio, wherein an aqueous solution of sodium hydroxide is added to the methanol, and stirring, thereby obtaining a methanol extract containing free-astaxanthin and separating the dodecane solvent from the methanol extract (step 2); and
recycling the dodecane solvent separated from the alcoholic extract in the step 2 by carrying out the step 1 and the step 2 repeatedly (step 3).
2. The method according to claim 1, wherein the dodecane solvent extract is obtained by phase separation from the cell culture through spontaneous standing by density difference between the dodecane solvent and the cell culture in the step 1, and the methanol extract containing free-astaxanthin is obtained by phase separation from the dodecane solvent through spontaneous standing by density difference between the dodecane solvent and the methanol in the step 2.
US11/677,302 2006-02-21 2007-02-21 Method for selective separation of free-astaxanthin from green algae Haematococcus pluvialis Expired - Fee Related US7785823B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060016826A KR100708386B1 (en) 2006-02-21 2006-02-21 Method for selective separation free-astaxanthin from haematococcus pluvialis
KR10-2006-0016826 2006-02-21

Publications (2)

Publication Number Publication Date
US20070196894A1 US20070196894A1 (en) 2007-08-23
US7785823B2 true US7785823B2 (en) 2010-08-31

Family

ID=38181532

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/677,302 Expired - Fee Related US7785823B2 (en) 2006-02-21 2007-02-21 Method for selective separation of free-astaxanthin from green algae Haematococcus pluvialis

Country Status (3)

Country Link
US (1) US7785823B2 (en)
JP (1) JP4504987B2 (en)
KR (1) KR100708386B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584662A (en) * 2011-12-19 2012-07-18 青岛赛特香料有限公司 Method for preparing water-soluble lutein

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007114461A1 (en) * 2006-03-28 2007-10-11 Asahi Kasei Pharma Corporation Process for production of carotenoid
JP4969370B2 (en) 2007-08-29 2012-07-04 Ｊｘ日鉱日石エネルギー株式会社 Method for producing carotenoid
EP2085381B1 (en) 2008-01-30 2010-08-11 Bioptik Technology, Inc. Method for obtaining natural astaxanthin from eggs and gonads of snails
CL2008001699A1 (en) 2008-06-09 2010-02-05 Univ Chile DNA sequence encoding enzyme with cytochrome p450 reductase activity of x. dendrorhous; encoded polypeptide sequence; vector or plasmid; hesped cell; polypeptide production process; astaxanthin production process from beta-carotene; compositions, products and / or formulations.
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
US8481072B2 (en) 2009-07-23 2013-07-09 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US8557275B2 (en) 2009-07-23 2013-10-15 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9238043B2 (en) 2009-07-23 2016-01-19 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using algae based oils
US9216164B2 (en) 2009-07-23 2015-12-22 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA
US9399047B2 (en) 2009-07-23 2016-07-26 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and roe extract
US9913810B2 (en) 2009-07-23 2018-03-13 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using phospholipids and astaxanthin
US8303818B2 (en) * 2010-06-24 2012-11-06 Streamline Automation, Llc Method and apparatus using an active ionic liquid for algae biofuel harvest and extraction
US8450111B2 (en) 2010-03-02 2013-05-28 Streamline Automation, Llc Lipid extraction from microalgae using a single ionic liquid
KR101251191B1 (en) 2010-11-04 2013-04-08 김성천 Method and Device for Producing Cell and Fat Solubles Material by Culturing Cell
TWI414362B (en) 2011-05-18 2013-11-11 Ind Tech Res Inst Extraction apparatus
KR101588585B1 (en) * 2014-07-15 2016-01-28 한국에너지기술연구원 Method for extracting astaxantin from microalgae effectively using cell germination
CN104762211A (en) * 2015-05-04 2015-07-08 厦门大学 Wall-breaking method for haematococcus pluvialis
CN105254551B (en) * 2015-11-10 2017-08-25 中国中医科学院中药研究所 The method of rapid extraction astaxanthin from haematococcus pluvialis
CN106802281A (en) * 2015-11-26 2017-06-06 骆野鸣 A kind of method of quick measure sporoderm-broken rate of spore of haematococcus pluvialis
WO2021056357A1 (en) * 2019-09-26 2021-04-01 云南爱尔康生物技术有限公司 Method for preparing astaxanthin oil by cold pressing haematococcus pluvialis
CN113185438A (en) * 2021-04-28 2021-07-30 云南爱尔康生物技术有限公司 Preparation method of high-purity astaxanthin ester from haematococcus pluvialis
CN115557869A (en) * 2022-10-11 2023-01-03 北京工商大学 Deep eutectic solvent and method for extracting astaxanthin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453565A (en) * 1990-07-20 1995-09-26 Unilever Patent Holdings B.V. Astaxanthin from flowers of the genus adonis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199887D0 (en) * 1987-04-15 1987-04-15 Danisco Bioteknologi As yeast strain
GB2358862B (en) * 1999-12-21 2004-07-21 Fermentron Ltd Processes for Extracting Carotenoids from Biomass Carotenoid Sources
JP4859006B2 (en) * 2001-05-25 2012-01-18 富士化学工業株式会社 Stable astaxanthin-cyclodextrin inclusion compound and method for producing the same, and liquid, food and drink, feed, pharmaceuticals and cosmetics containing the inclusion compound
KR101009000B1 (en) * 2003-07-01 2011-01-17 학교법인 포항공과대학교 Method of producing astaxanthin
KR20050096556A (en) * 2004-03-31 2005-10-06 정세영 Skin whitening ingredients containing astaxanthin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453565A (en) * 1990-07-20 1995-09-26 Unilever Patent Holdings B.V. Astaxanthin from flowers of the genus adonis

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Hejazi et al. (I), (Trends in Biotechnology, vol. 22, pp. 189-194, 2004. *
Hejazi et al. (II), Biotechnology and Bioengineering, vol. 79, 2002, pp. 29-35. *
Yuan et al. , Food Chemistry, vol. 68, pp. 443-448, 2000. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102584662A (en) * 2011-12-19 2012-07-18 青岛赛特香料有限公司 Method for preparing water-soluble lutein

Also Published As

Publication number Publication date
JP4504987B2 (en) 2010-07-14
US20070196894A1 (en) 2007-08-23
KR100708386B1 (en) 2007-04-18
JP2007222168A (en) 2007-09-06

Similar Documents

Publication Publication Date Title
US7785823B2 (en) Method for selective separation of free-astaxanthin from green algae Haematococcus pluvialis
Khoo et al. Recent advances in biorefinery of astaxanthin from Haematococcus pluvialis
CN101665446B (en) Extract method of capsaicine and capsanthin
EP2082056B1 (en) Preparation of retinyl esters
WO2010146331A3 (en) Process for production of sugars and alcohols from a cellulosic material
Mussagy et al. Rhodotorula sp.–based biorefinery: a source of valuable biomolecules
EP2571996B1 (en) Process for production of high purity beta-carotene and lycopene crystals from fungal biomass
CN105431529A (en) Compositions and methods for fungal lipid production
CN100519497C (en) Method for extraction separation of dichloropropanol from dichloropropanol hydrochloric water solution
Azizi et al. Supplementation with polyalcohols and sequential mixotrophy dilution photoinduction strategy boost the accumulation of astaxanthin by Haematococcus pluvialis
CN103012230A (en) Novel process for high-effective extraction of carotenoid in Blakeslea trispora
ES2195758A1 (en) Improved method of production of lycopene by the fermentation of selected strains of blakeslea trispora.
US11060118B2 (en) Production of vanillin by fermentation
WO2012033359A3 (en) Method of preparing alkyl butyrate from fermented liquid using microorganisms
CN114751848A (en) Method for preparing astaxanthin essential oil based on phaffia rhodozyma
KR101588585B1 (en) Method for extracting astaxantin from microalgae effectively using cell germination
JP2013136549A (en) Method of producing long-chain dicarboxylic acid
KR100741644B1 (en) Method for extracting astaxanthin using surfactant from green algaes
CA2684914C (en) Method for the intensive extraction of cellular compounds from micro-organisms by continuous culture and extraction, and corresponding device
KR101766956B1 (en) Method for producing esters from microbial fermentation using high-pressure carbon dioxide gas
US6653498B2 (en) Process for preparing optically active cyanohydrins and secondary products
EP4424809A1 (en) Method for converting methane-containing gas streams into osmolytes using a bacteria culture in a taylor-flow bioreactor
JP2003144188A (en) New method for producing xanthophyll educt and method for purifying the same
EP3152314A1 (en) Glycerol-based fermentation process
KR101555639B1 (en) Method for converting aloeresin a to aloesin

Legal Events

Date Code Title Description
AS Assignment

Owner name: SUNGKYUNKWAN UNIVERSITY, KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SIM, SANG-JUN;KANG, CHANG-DEOK;REEL/FRAME:019162/0128

Effective date: 20070314

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552)

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20220831